Clinical characteristics of the asthma bronchiectasis phenotype.

[1]  Trung Nghia Tran,et al.  Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study , 2022, Thorax.

[2]  K. Jin,et al.  Clinical deterioration and lung function change in patients with concomitant asthma and bronchiectasis. , 2022, Journal of Allergy and Clinical Immunology: In Practice.

[3]  G. Parraga,et al.  Asthma control, Airway mucus and 129Xe MRI ventilation after a single Benralizumab dose. , 2022, Chest.

[4]  H. Matsumoto.  Bronchiectasis in severe asthma and asthmatic components in bronchiectasis. , 2021, Respiratory investigation.

[5]  Clinical Research Fellow Dr Rory Chan,et al.  Impact of Nasal Polyps on Endotype and Phenotype in Moderate to Severe Asthma Patients. , 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  J. Corren,et al.  Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma. , 2020, The journal of allergy and clinical immunology. In practice.

[7]  M. Tunney,et al.  British Thoracic Society Guideline for bronchiectasis in adults , 2018, Thorax.

[8]  S. Quirce,et al.  Bronchiectasis in severe asthma: Clinical features and outcomes. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  E. Hoffman,et al.  Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction , 2018, The Journal of clinical investigation.

[10]  Ian D Pavord,et al.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial , 2012, The Lancet.

[11]  C. Salome,et al.  Randomized , Placebo-controlled Clinical Trial of an Aerosolized β 2-Agonist for Treatment of Acute Lung Injury , 2011 .